Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $13.1500 (-1.05%) ($12.9400 - $13.3700) on Wed. Apr. 24, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.2% (three month average) | RSI | 39 | Latest Price | $13.1500(-1.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -0.8% a day on average for past five trading days. | Weekly Trend | FOLD declines -4.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(61%) XBI(57%) IWO(55%) IWM(52%) IWC(50%) | Factors Impacting FOLD price | FOLD will decline at least -1.6% in a week (0% probabilities). TLT(-15%) VXX(-14%) UUP(-13%) VIXM(-8%) IFRA(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.6% (StdDev 3.2%) | Hourly BBV | 0 () | Intraday Trend | -1.6% | | | |
|
1 - 5 Day Possible Target | $6.1(-53.61%) | Resistance Level | $13.57 | 5 Day Moving Average | $12.94(1.62%) | 10 Day Moving Average | $13.35(-1.5%) | 20 Day Moving Average | $13.57(-3.1%) | To recent high | -8.7% | To recent low | 19.9% | Market Cap | $3.396b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |